Sponsor or institution

Clinical trials and research at The First Affiliated Hospital of Xiamen University

• 58Clinical trials
• 3New in 30 days
• 1Country

Newest trials

All recruiting trials (58)

• 68Ga-XHER2 PET/CT imaging to see HER2 in solid tumors

  A noninvasive PET/CT imaging test using 68Ga-XHER2 is being tried to see if it reflects HER2 levels in solid tumors.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07885436

• 68Ga-XMFH01 PET/FL imaging to guide prostate cancer surgery

  This study tests a new dual-modality imaging probe, 68Ga-XMFH01, to preoperatively detect prostate cancer and guide the surgeon with fluorescence during operations in adults with newly diagnosed prostate cancer.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07885423

• Anxiety and Depression in Patients with Hematologic Cancers

  This study tests whether anxiety and depression levels before and after treatment are linked to treatment outcomes in people newly diagnosed with lymphoma, multiple myeloma, or leukemia.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07883070

• VCC combination in relapsed or refractory AML

  A group of adults with relapsed or refractory AML will receive a three-drug combo (venetoclax, chidamide, and chiglitazar sodium) to see if it helps control the leukemia.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07783100

• Orelabrutinib plus Pola-R-CHP as first-line treatment for intermediate- to high-risk DLBCL

  This trial tests whether adding orelabrutinib to the Pola-R-CHP regimen can improve outcomes for adults with intermediate- to high-risk newly diagnosed DLBCL.

  Recruiting at 2 sites The First Affiliated Hospital of Xiamen University · Xiamen, Fujian and 1 other locations · NCT07778212

• Trop-2 Targeted PET/CT for Recurrent and Metastatic Thyroid Cancer

  This study tests whether a Trop-2 targeted PET/CT scan can better detect recurrent or metastatic thyroid cancer in adults than another PET/CT scan (FAPI).

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07753499

• Hypofractionated Radiotherapy plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL

  This study tests a combination therapy—hypofractionated radiotherapy with GM-CSF, pomalidomide, and glofitamab—for adults newly diagnosed with primary CNS DLBCL to see if it helps control the disease.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07749365

• DLL3-targeted PET/CT for small cell lung cancer

  This study tests whether DLL3-targeted PET/CT can better detect lesions in people with suspected or confirmed small cell lung cancer compared with standard imaging.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07677787

• GPC3-targeted PET/CT for suspected or confirmed liver cancer

  This study tests whether a GPC3-targeted PET/CT scan can help detect liver tumors in people with suspected or confirmed hepatocellular carcinoma, alongside MRI.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07677774

• Eye drops from umbilical cord stem cell vesicles to help dry eye

  A tiny drop of human umbilical cord stem cell–derived vesicles is applied to the eye daily for four weeks to see if it helps dry eye symptoms and signs.

  Recruiting Early Phase 1 The First Affiliated Hospital of Xiamen University · Xiamen, China · NCT07623382

• Tofacitinib for steroid‑resistant moderate-to-severe thyroid eye disease

  This will test whether taking oral tofacitinib (5 mg twice daily) for 24 weeks can reduce eye bulging and inflammation in adults with moderate-to-severe thyroid eye disease who don't respond to or cannot take high-dose steroids.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07547930

• DLL3-targeted PET/CT for detecting neuroendocrine carcinoma

  We are testing a DLL3-targeted PET/CT scan to see if it better finds tumors in adults with suspected or confirmed neuroendocrine carcinoma.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07458906

• 68Ga-XACP3 PET/CT for detecting prostate cancer lesions

  This study will test whether 68Ga-XACP3 PET/CT can find tumor lesions in adults with prostate cancer or suspected recurrence compared with the standard 68Ga-PSMA PET/CT.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07242014

• Using 68Ga-MY6349 PET/CT to track response to Trop2 antibody‑drug therapy in NSCLC

  This will see if serial 68Ga-MY6349 PET/CT scans can predict how people with metastatic NSCLC respond to Trop2-targeted antibody‑drug treatment.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07151898

• Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma

  This study uses PET/CT imaging with two tracers to see if they can better stage NPC and predict early response to neoadjuvant immunotherapy in adults with newly diagnosed NPC.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen · NCT07137052

• Effect of transcutaneous electrical acupoint stimulation on postoperative gastrointestinal dysfunction after laparoscopic urological surgery

  This study tests whether placing small electrical pulses on acupuncture points after laparoscopic urological surgery can help reduce postoperative GI problems and checks that it is safe.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07133620

• Iparomlimab/Tuvorlimab (QL1706) plus modified TPF induction for locally advanced nasopharyngeal carcinoma

  This trial will test whether adding the dual-antibody Iparomlimab/Tuvorlimab (QL‑1706) to a modified TPF chemotherapy regimen as induction therapy helps adults with newly diagnosed, locally advanced nasopharyngeal carcinoma.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07085234

• 68Ga-MY6349 PET/CT to detect Trop-2 in solid tumors

  This scan will see if a new 68Ga-MY6349 PET/CT can detect Trop‑2 on tumors in adults with solid tumors.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07046702

• Using 68Ga‑MY6349 PET/CT to track response to Trop2‑targeted therapy in breast cancer

  This study tries to see if repeated 68Ga‑MY6349 PET/CT scans can predict how well Trop2‑targeted antibody‑drug conjugate (Trop2‑ADC) treatment will work for adults with metastatic breast cancer.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07046689

• T-cell developmental status in people with blood cancers

  This project will see if tracking T-cell development and immune markers before and after treatment can help guide care for adults with B-cell lymphoma or multiple myeloma.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07035938

• Trilaciclib given before sacituzumab tirumotecan to protect bone marrow in EGFR-mutated advanced NSCLC

  This trial will test whether giving trilaciclib before sacituzumab tirumotecan helps protect the blood and reduce blood-related side effects in people with advanced EGFR‑mutated non-small cell lung cancer who have stopped responding to EGFR-TKI therapy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06992739

• Using CAIX-targeted PET imaging for kidney cancer diagnosis

  This study is testing a new type of PET imaging that targets kidney cancer to see if it can improve how doctors diagnose and stage the disease compared to regular CT scans.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen · NCT06956144

• Trilaciclib plus docetaxel for second-line or later advanced non-small cell lung cancer

  This test gives trilaciclib before docetaxel to see if it protects bone marrow and reduces low blood counts in people with advanced or metastatic non-small cell lung cancer receiving second-line or later chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06929936

• GB5005 CART-cell injection for treating relapsed B-cell non-Hodgkin lymphoma

  This study is testing a new CAR-T cell treatment called GB5005 to see if it can help people with relapsed B-cell non-Hodgkin lymphoma feel better and manage side effects.

  Recruiting Phase 1 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06875063

• Combination treatment for elderly patients with untreated acute myeloid leukemia

  This study is testing a new combination treatment for older patients with untreated acute myeloid leukemia to see if it can help them when standard chemotherapy isn't an option.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06827899

• Treatment for patients with relapsed follicular lymphoma using Axicabtagene Ciloleucel Injection

  This study is testing a new treatment called Axicabtagene Ciloleucel Injection to see if it can help Chinese patients with relapsed follicular lymphoma who have already tried other therapies.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06826118

• Comparing two and three cycles of chemotherapy with immunotherapy for advanced nasopharyngeal cancer

  This study is testing whether two cycles of chemotherapy combined with immunotherapy can help people with advanced nasopharyngeal cancer just as much as three cycles, but with fewer side effects.

  Recruiting at 3 sites Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian and 2 other locations · NCT06811844

• Evaluating thumbtack needle therapy for improving sleep and recovery after surgery

  This study is testing if thumbtack needle therapy can help women recover better and sleep more soundly after breast cancer surgery.

  Recruiting at 2 sites The First Affiliated Hospital of Xiamen University · Xiamen, Fujian and 1 other locations · NCT06757023

• Imaging PD-L1 Expression in Cancers Using 68Ga-NK224 PET

  This study is testing a new type of PET scan to see if it can accurately measure a protein in cancer tumors for people who have just been diagnosed or have already been treated for cancer.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06754345

• Treatment of relapsed or refractory acute myeloid leukemia with a new drug combination

  This study is testing a new combination of drugs to see if it can help people with relapsed or refractory acute myeloid leukemia feel better and improve their treatment outcomes.

  Recruiting Phase 1 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06737523

• Evaluating a new PET imaging agent for prostate cancer diagnosis

  This study is testing a new imaging agent for prostate cancer to see if it can help doctors find and monitor the disease more accurately than current methods.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06696326

• Focused radiation plus nimotuzumab followed by tislelizumab for oligoprogressive recurrent or metastatic nasopharyngeal cancer after prior immunotherapy

  This trial will try focused stereotactic radiation together with the antibody nimotuzumab, followed by the PD‑1 drug tislelizumab, in people whose recurrent or metastatic nasopharyngeal cancer has progressed at 1–5 spots after prior anti–PD‑1 treatment.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian and 1 other locations · NCT06676722

• Testing a new treatment for elderly patients with acute myeloid leukemia

  This study is testing a new treatment for older patients with acute myeloid leukemia to see if it is safe and effective for those who can't have the usual therapy.

  Recruiting Phase 1 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06651866

• Combining radiation therapy with lenalidomide and glofitamab for treating relapsed DLBCL

  This study is testing a new treatment combining radiation therapy with lenalidomide and glofitamab to see if it helps people with relapsed diffuse large B-cell lymphoma who haven't responded to other treatments.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06651853

• Using Thymalfasin and IL-2 to treat low lymphocyte levels in blood cancer patients

  This study is testing if a combination of two injections can help blood cancer patients with low lymphocyte levels feel better and improve their health.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06584006

• CAR-T cell therapy targeting BCMA for treating multiple myeloma

  This study is testing a new CAR-T cell therapy that targets a specific protein to see if it can help people with hard-to-treat multiple myeloma feel better.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06581640

• Combining Zanubrutinib and Obinutuzumab for Treating Newly Diagnosed Follicular Lymphoma

  This study is testing a new combination of two medications, Zanubrutinib and Obinutuzumab, to see if they can help people with newly diagnosed follicular lymphoma feel better and stay healthy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06553352

• Follow-up on Rituximab treatment for children's nephrotic syndrome

  This study looks at how well rituximab works and its safety for children with hard-to-treat nephrotic syndrome by reviewing their past treatment data.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06530004

• Combining Orelabrutinib and Rituximab for Treating Marginal Zone Lymphoma

  This study is testing if combining two medications, Orelabrutinib and Rituximab, can help adults with Marginal Zone Lymphoma who haven't responded to other treatments or can't have local therapy.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06478472

• Combining paclitaxel, apatinib, and adebrelimab for advanced gastric cancer treatment

  This study is testing a new combination of three drugs to see if it can help people with advanced stomach cancer who haven't had much success with other treatments.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Fuzhou, Fujian · NCT06415669

• Genomic biomarker-guided therapy for advanced prostate cancer

  This study is testing if personalized treatment based on genetic markers can help men with advanced prostate cancer before surgery.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06387056

• Evaluation of a new radioligand therapy for solid tumors

  This study is testing a new type of treatment for people with solid tumors that show a specific marker to see if it helps shrink the tumors and is safe to use.

  Recruiting Phase 1 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06375564

• Using All-trans Retinoic Acid with KPD for treating relapsed multiple myeloma

  This study is testing if a new combination of All-trans Retinoic Acid and a specific treatment can help people with relapsed multiple myeloma who haven't had success with other therapies.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06158412

• Combining Azacitidine with R-CHOP for treating TP53-mutated DLBCL

  This study is testing if adding Azacitidine to the standard R-CHOP treatment can help people with untreated Diffuse Large B-cell Lymphoma who have TP53 mutations feel better and live longer.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06158399

• Combining Chidamide and Linperlisib for treating difficult cases of follicular lymphoma

  This study is testing if combining two drugs, Chidamide and Linperlisib, can help people with tough cases of follicular lymphoma who haven't responded to other treatments.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06158386

• Using 68Ga-FAPI PET/CT imaging to diagnose and evaluate myelofibrosis.

  This study is testing a new imaging method using 68Ga-FAPI PET/CT to see if it can better diagnose myelofibrosis compared to regular CT scans.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06151119

• Treatment of relapsed or refractory peripheral T-cell lymphoma with Chidamide and Duvalisib

  This study is testing if a new combination of two drugs, Chidamide and Duvalisib, can help people with hard-to-treat peripheral T-cell lymphoma feel better and live longer.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06151106

• Combining lenalidomide with G-CHOP for treating newly diagnosed DLBCL with FL

  This study is testing if adding lenalidomide to the G-CHOP treatment can help people newly diagnosed with diffuse large B-cell lymphoma and follicular lymphoma feel better and live longer.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06151080

• Treatment for advanced liver cancer using TACE with new medications

  This study is testing a new treatment combining TACE with two medications to see if it helps people with advanced liver cancer who can't have surgery.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05970666

• Imaging with a new PET agent for SSTR2 positive diseases

  This study is testing a new imaging agent to see if it can provide better results for patients with SSTR2 positive diseases compared to the current standard imaging method.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05873777

• Combining Pulmonary Vein Isolation with Renal Denervation for Atrial Fibrillation and Hypertension

  This study is testing if combining two treatments, Pulmonary Vein Isolation and Renal Denervation, can help people with Atrial Fibrillation and high blood pressure feel better and have better results than using just one treatment alone.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05841615

• Investigating the effects of renal nerve denervation on kidney function

  This study is testing if a procedure called renal nerve denervation can improve kidney function in adults with high blood pressure who haven't had success with other medications.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05612906

• Treatment for elderly patients with newly diagnosed acute myeloid leukemia

  This study is testing a new treatment plan for older patients with newly diagnosed acute myeloid leukemia to see if it can help them do better without the harsh side effects of standard chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05603884

• Combining Venetoclax, Chidamide, and Azacitidine for treating relapsed AML

  This study is testing a new combination of three drugs to see if it can help people with relapsed acute myeloid leukemia feel better and achieve longer-lasting results.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT05305859

• Comparing two types of PET scans for cancer diagnosis

  This study is testing whether a new type of PET scan can find cancer better than the standard scan in patients who have or might have tumors.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT04416165

• Observational study of nurses' health in Xiamen, China

  This study looks at how different factors affect the health of nurses in Xiamen, China, especially focusing on chronic diseases like high blood pressure over five years.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT03799653

• Investigating the effects of stopping anti-inflammatory drugs in patients with axial spondyloarthritis

  This study is testing whether stopping anti-inflammatory drugs helps people with axial spondyloarthritis who are in remission stay that way without having flare-ups.

  Recruiting The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT03425812

• Comparing Liraglutide and Insulin Glargine for Type 2 Diabetes Management

  This study is testing if adding a medication called Liraglutide to insulin can help overweight and obese people with uncontrolled type 2 diabetes manage their blood sugar better and avoid weight gain compared to using a different type of insulin alone.

  Recruiting Phase 4 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT03087032

Quick answers

How many clinical trials run by The First Affiliated Hospital of Xiamen University are recruiting right now?

58, as of November 12, 2026. 3 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 24, Phase 1: 4, Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →